Paul Tudor Jones's IMVT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 57,145 shares of Immunovant, Inc. (IMVT) worth $2.2 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in IMVT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 90,766 shares. Largest reduction occurred in Q2 2024, reducing 87,397 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Immunovant (IMVT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunovant (IMVT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +57,145 | New Buy | 57,145 | $38.53 |
| Q1 2026 | -25,600 | Sold Out | 0 | $0.00 |
| Q4 2025 | -65,166 | Reduce 71.80% | 25,600 | $25.42 |
| Q3 2025 | +90,766 | New Buy | 90,766 | $16.12 |
| Q2 2024 | -87,397 | Sold Out | 0 | $0.00 |
| Q1 2024 | +49,055 | Add 127.94% | 87,397 | $32.31 |
| Q4 2023 | +38,342 | New Buy | 38,342 | $42.13 |
| Q3 2023 | -14,333 | Sold Out | 0 | $0.00 |
| Q2 2023 | -52,686 | Reduce 78.61% | 14,333 | $18.97 |
| Q1 2023 | +67,019 | New Buy | 67,019 | $0.02 |
Paul Tudor Jones's Immunovant Investment FAQs
Paul Tudor Jones first purchased Immunovant, Inc. (IMVT) in Q1 2023, acquiring 67,019 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Immunovant, Inc. (IMVT) for 10 quarters since Q1 2023.
Paul Tudor Jones's largest addition to Immunovant, Inc. (IMVT) was in Q3 2025, adding 90,766 shares worth $1.46 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 57,145 shares of Immunovant, Inc. (IMVT), valued at approximately $2.2 M.
As of the Q2 2026 filing, Immunovant, Inc. (IMVT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Immunovant, Inc. (IMVT) was 90,766 shares, as reported at the end of Q3 2025.